SMTL ID : 6vnm.1 (1 other biounit)

JAK2 JH1 in complex with SY5-103

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.20 Å

Oligo State

monomer

Ligands

1 x R5Y: 4-[1-(but-3-en-1-yl)-1H-pyrazol-4-yl]-N-[4-(piperidin-4-yl)phenyl]-7H-pyrrolo[2,3-d]pyrimidin-2-amine(Non-covalent)

R5Y.1: 17 residues within 4Å: Chain A: Q.29, L.31, G.32, V.39, A.56, V.87, M.105, E.106, Y.107, L.108, P.109, G.111, R.156, N.157, L.159, G.169, D.170 7 PLIP interactions: 7 interactions with chain A Hydrophobic interactions: A:L.31, A:Y.107, A:L.159, A:L.159 Hydrogen bonds: A:E.106, A:L.108, A:L.108

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Davis, R.R. et al., Structural Insights into JAK2 Inhibition by Ruxolitinib, Fedratinib, and Derivatives Thereof. J.Med.Chem. (2021)

Release Date

2021-02-17

Peptides

Tyrosine-protein kinase JAK2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
B

Tyrosine-protein kinase JAK2

Related Entries With Identical Sequence